financetom
Business
financetom
/
Business
/
Kkr Fs Income Trust Select Insider Bought Shares Worth $11,428,571, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Kkr Fs Income Trust Select Insider Bought Shares Worth $11,428,571, According to a Recent SEC Filing
Mar 26, 2024 1:35 PM

04:25 PM EDT, 03/26/2024 (MT Newswires) -- Michael C. Forman, 10% Owner, Director, President & CEO, on March 26, 2024, executed a purchase for 457,143 shares in Kkr Fs Income Trust Select (NONE) for $11,428,571. Following the Form 4 filing with the SEC, Forman has control over a total of 400,315 shares of the company, with 400,315 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1975736/000110465924039034/xslF345X03/tm249865-4_4seq1.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Update: Market Chatter: Nvidia Urged by Chinese State Media to Provide 'Security Proofs'
Update: Market Chatter: Nvidia Urged by Chinese State Media to Provide 'Security Proofs'
Aug 1, 2025
10:09 AM EDT, 08/01/2025 (MT Newswires) -- (Updated to add Nvidia's ( NVDA ) comment in the fourth paragraph.) Nvidia ( NVDA ) was urged Friday by a Chinese state-controlled media outlet to present convincing security proofs in order to eliminate Chinese users' concerns related to alleged security risks in its chips, Reuters reported Friday, citing a commentary published by...
US FDA declines to approve Regeneron's blood cancer therapy for second time
US FDA declines to approve Regeneron's blood cancer therapy for second time
Aug 1, 2025
Aug 1 (Reuters) - Regeneron said on Friday the U.S. Food and Drug Administration has once again declined to approve its blood cancer therapy, this time in relation to observations from the regulator's inspection at a third-party manufacturing site. The company was seeking approval for its drug odronextamab to treat follicular lymphoma - a type of cancer that begins in...
Omega Healthcare Q2 revenue misses expectations, net income rises
Omega Healthcare Q2 revenue misses expectations, net income rises
Aug 1, 2025
(Repeats to attach to corrected alerts, no changes to text) Overview * Omega Q2 net income rises to $140 mln, up from $117 mln last year * Company completed $527 mln in new investments during Q2 * Revenue missed analyst expectations, per LSEG data Outlook * Omega raises 2025 AFFO guidance to $3.04-$3.07 per share * Company expects Genesis to...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved